Summary
Federal regulators approved a new weight-loss pill called Foundayo by Eli Lilly. This pill offers an alternative to injectable weight-loss drugs and aims to improve access to obesity treatment for Americans.
Key Facts
- The FDA approved Eli Lilly's new weight-loss pill, Foundayo, which is taken once daily.
- Foundayo works by mimicking a hormone that helps control appetite and fullness.
- The pill can be taken without strict dietary restrictions, unlike some other oral GLP-1 medications.
- Foundayo could make weight-loss treatment more accessible and affordable, especially for those avoiding injections.
- Eli Lilly plans to start shipping the drug on Monday, with insured patients potentially paying as little as $25 monthly.
- In a trial, participants losing weight with Foundayo lost an average of 11.2% of their body weight.
- The FDA used a fast-track program to review and approve Foundayo in just 50 days.
